Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
(OP:
POLBF
)
0.0425
UNCHANGED
Last Price
Updated: 11:43 AM EDT, Jul 10, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about POLBF
Poolbeg Pharma's POLB 001 immuno-modulator II receives fully-granted patent from US Patent Office
May 08, 2024
Poolbeg Pharma's POLB 001 immuno-modulator II receives fully-granted patent from US Patent Office
Via
News Direct
Topics
Intellectual Property
Poolbeg Pharma unveils new collaboration agreement
October 18, 2023
--News Direct--
Via
News Direct
Poolbeg Pharma "moving forward rapidly" with POLB001
September 13, 2023
--News Direct--
Via
News Direct
Topics
Artificial Intelligence
Poolbeg Pharma and CytoReason identify "very exciting influenza targets"
June 29, 2023
Poolbeg Pharma and CytoReason identify "very exciting influenza targets"
Via
News Direct
Topics
Artificial Intelligence
Poolbeg Pharma sees "significant commercial opportunity" in oral vaccines
June 22, 2023
Poolbeg Pharma sees "significant commercial opportunity" in oral vaccines
Via
News Direct
Poolbeg Pharma "in a very healthy cash position" after first full year of operations
March 30, 2023
Poolbeg Pharma "in a very healthy cash position" after first full year of operations
Via
News Direct
Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma
March 09, 2023
Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma
Via
News Direct
Poolbeg Pharma "couldn't be happier" with POLB 001 human challenge trial data
March 02, 2023
Poolbeg Pharma "couldn't be happier" with POLB 001 human challenge trial data
Via
News Direct
Poolbeg Pharma "really open" to different types of deal for POLB 001
March 01, 2023
Poolbeg Pharma "really open" to different types of deal for POLB 001
Via
News Direct
Poolbeg Pharma announces expansion of POLB 001 into oncology
January 18, 2023
Poolbeg Pharma announces expansion of POLB 001 into oncology
Via
News Direct
Topics
Intellectual Property
Poolbeg Pharma upbeat on preliminary influenza drug results
January 09, 2023
Poolbeg Pharma upbeat on preliminary influenza drug results
Via
News Direct
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today